{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:09:26Z","timestamp":1792699766161,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017534","name":"Inner Mongolia Medical University","doi-asserted-by":"publisher","award":["YKD2022ZD009"],"award-info":[{"award-number":["YKD2022ZD009"]}],"id":[{"id":"10.13039\/100017534","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017534","name":"Inner Mongolia Medical University","doi-asserted-by":"publisher","award":["YKD2025ZD005"],"award-info":[{"award-number":["YKD2025ZD005"]}],"id":[{"id":"10.13039\/100017534","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004763","name":"Natural Science Foundation of Inner Mongolia Autonomous Region","doi-asserted-by":"publisher","award":["2023MS08033"],"award-info":[{"award-number":["2023MS08033"]}],"id":[{"id":"10.13039\/501100004763","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004763","name":"Natural Science Foundation of Inner Mongolia Autonomous Region","doi-asserted-by":"publisher","award":["2024MS08039"],"award-info":[{"award-number":["2024MS08039"]}],"id":[{"id":"10.13039\/501100004763","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.bcp.2026.117700","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T16:03:34Z","timestamp":1767974614000},"page":"117700","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Integrative analyses of network pharmacology and bioinformatics reveal the synergistic antitumor effects of cantharidin and ginsenosides Rg3 on hepatocellular carcinoma"],"prefix":"10.1016","volume":"246","author":[{"given":"Xianggang","family":"Gou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongzheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuehua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henye","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haisheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9924-9348","authenticated-orcid":false,"given":"Jia","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2026.117700_b0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.bcp.2026.117700_b0010","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.bcp.2026.117700_b0015","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.livres.2023.11.004","article-title":"Hepatocellular carcinoma recurrence: predictors and management","volume":"7","author":"Abdelhamed","year":"2023","journal-title":"Liver Res."},{"issue":"8","key":"10.1016\/j.bcp.2026.117700_b0020","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/j.cgh.2023.01.039","article-title":"Breakthroughs in hepatocellular carcinoma therapies","volume":"21","author":"Singal","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"10","key":"10.1016\/j.bcp.2026.117700_b0025","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"Suppl","key":"10.1016\/j.bcp.2026.117700_b0030","doi-asserted-by":"crossref","first-page":"S228","DOI":"10.3350\/cmh.2024.0824","article-title":"Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment","volume":"31","author":"Hwang","year":"2025","journal-title":"Clin. Mol. Hepatol."},{"issue":"2","key":"10.1016\/j.bcp.2026.117700_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2025.101781","article-title":"Treatment for hepatocellular carcinoma after immunotherapy","volume":"30","author":"Chan","year":"2025","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.bcp.2026.117700_b0040","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.2147\/IJN.S509409","article-title":"Progress in the application of novel nanomaterials in targeted therapy for liver cancer","volume":"20","author":"Wei","year":"2025","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bcp.2026.117700_b0045","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2147\/JHC.S504457","article-title":"Systemic treatment for unresectable hepatocellular carcinoma: a surgeon's perspective","volume":"12","author":"Zhu","year":"2025","journal-title":"J. Hepatocell. Carcinoma."},{"issue":"5","key":"10.1016\/j.bcp.2026.117700_b0050","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3390\/curroncol32050264","article-title":"Role of immunotherapy in the treatment of hepatocellular carcinoma","volume":"32","author":"Dobrosotskaya","year":"2025","journal-title":"Curr. Oncol."},{"issue":"3","key":"10.1016\/j.bcp.2026.117700_b0055","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1158\/1078-0432.CCR-21-1258","article-title":"NASH and hepatocellular carcinoma: immunology and immunotherapy","volume":"29","author":"Pinter","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2026.117700_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2025.119386","article-title":"Regulatory mechanisms of signaling pathways in liver cancer treatment with traditional chinese medicine","volume":"342","author":"Zheng","year":"2025","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2026.117700_b0065","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12943-024-02101-z","article-title":"Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma","volume":"23","author":"Chan","year":"2024","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2026.117700_b0070","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12943-025-02378-8","article-title":"The tumor microenvironment in hepatocellular carcinoma: mechanistic insights and therapeutic potential of traditional chinese medicine","volume":"24","author":"Su","year":"2025","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2026.117700_b0075","article-title":"Traditional chinese medicine enhances the effectiveness of immune checkpoint inhibitors in tumor treatment: a mechanism discussion","volume":"338","author":"Wang","year":"2025","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bcp.2026.117700_b0080","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2147\/CMAR.S503071","article-title":"The application of traditional chinese medicine-derived formulations in cancer immunotherapy: a review","volume":"17","author":"Li","year":"2025","journal-title":"Cancer Manag. Res."},{"issue":"14","key":"10.1016\/j.bcp.2026.117700_b0085","doi-asserted-by":"crossref","first-page":"6088","DOI":"10.7150\/thno.72509","article-title":"Self-assembled traditional chinese nanomedicine modulating tumor immunosuppressive microenvironment for colorectal cancer immunotherapy","volume":"12","author":"Mao","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.bcp.2026.117700_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107788","article-title":"Targeting tumor-associated macrophage polarization with traditional chinese medicine active ingredients: dual reversal of chemoresistance and immunosuppression in tumor microenvironment","volume":"216","author":"Qi","year":"2025","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.bcp.2026.117700_b0095","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1142\/S0192415X2450006X","article-title":"The effectiveness of traditional chinese medicine in treating malignancies via regulatory cell death pathways and the tumor immune microenvironment: a review of recent advances","volume":"52","author":"Fu","year":"2024","journal-title":"Am. J. Chin. Med."},{"issue":"7","key":"10.1016\/j.bcp.2026.117700_b0100","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1142\/S0192415X2350074X","article-title":"The role of traditional chinese medicine in cancer immunotherapy: current status and future directions","volume":"51","author":"Xie","year":"2023","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.bcp.2026.117700_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.117577","article-title":"Modified Biejia Jianwan decoction restrains PD-L1-mediated immune evasion through the HIF-1\u03b1\/STAT3\/NF-\u03baB signaling pathway","volume":"322","author":"Tian","year":"2024","journal-title":"J. Ethnopharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2026.117700_b0110","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/s41419-024-06685-8","article-title":"Arsenic trioxide augments immunogenic cell death and induces cGAS-STING-IFN pathway activation in hepatocellular carcinoma","volume":"15","author":"Li","year":"2024","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.bcp.2026.117700_b0115","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1159\/000540857","article-title":"Chinese expert consensus on the combination of targeted therapy and immunotherapy with locoregional therapy for intermediate\/advanced hepatocellular carcinoma","volume":"14","author":"Bi","year":"2024","journal-title":"Liver Cancer."},{"issue":"5","key":"10.1016\/j.bcp.2026.117700_b0120","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/j.1349-7006.2010.01523.x","article-title":"Cantharidin, a potent and selective PP2A inhibitor, induces an oxidative stress-independent growth inhibition of pancreatic cancer cells through G2\/M cell-cycle arrest and apoptosis","volume":"101","author":"Li","year":"2010","journal-title":"Cancer Sci."},{"issue":"18","key":"10.1016\/j.bcp.2026.117700_b0125","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.2174\/0929867330666221103151537","article-title":"Exploring cantharidin and its analogues as anticancer agents: a review","volume":"30","author":"Li","year":"2023","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bcp.2026.117700_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116012","article-title":"Antitumor potential of the protein phosphatase inhibitor, cantharidin, and selected derivatives","volume":"32","author":"Ren","year":"2021","journal-title":"Bioorg. Med. Chem."},{"issue":"14","key":"10.1016\/j.bcp.2026.117700_b0135","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.3390\/molecules25143279","article-title":"Anticancer attributes of cantharidin: involved molecular mechanisms and pathways","volume":"25","author":"Naz","year":"2020","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.bcp.2026.117700_b0140","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009099","article-title":"Cantharidin overcomes IL-2R\u03b1 signaling-mediated vorinostat resistance in cutaneous T-cell lymphoma through reactive oxygen species","volume":"12","author":"Zhu","year":"2024","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2026.117700_b0145","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12906-023-03975-0","article-title":"Cantharidin suppresses hepatocellular carcinoma development by regulating EZH2\/H3K27me3-dependent cell cycle progression and antitumour immune response","volume":"23","author":"Yan","year":"2023","journal-title":"BMC Complement Med. Ther."},{"issue":"1","key":"10.1016\/j.bcp.2026.117700_b0150","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1186\/s12885-023-11594-8","article-title":"Integrative analysis of the molecular signature of target genes involved in the antitumor effects of cantharidin on hepatocellular carcinoma","volume":"23","author":"Yan","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bcp.2026.117700_b0155","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/2197071","article-title":"Cantharidin inhibits proliferation of liver cancer by inducing DNA damage via KDM4A-dependent Histone H3K36 Demethylation","volume":"2022","author":"Wei","year":"2022","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.bcp.2026.117700_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104868","article-title":"Cantharidin treatment inhibits hepatocellular carcinoma development by regulating the JAK2\/STAT3 and PI3K\/Akt pathways in an EphB4-dependent manner","volume":"158","author":"Zhu","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"Pt 2","key":"10.1016\/j.bcp.2026.117700_b0165","article-title":"The anti-hepatocellular carcinoma effect of Aidi injection was related to the synergistic action of cantharidin, formononetin, and isofraxidin through BIRC5, FEN1, and EGFR","volume":"319","author":"Lu","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bcp.2026.117700_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154231","article-title":"Synergistic antitumor effects of compound-composed optimal formula from Aidi injection on hepatocellular carcinoma and colorectal cancer","volume":"103","author":"An","year":"2022","journal-title":"Phytomedicine"},{"issue":"34","key":"10.1016\/j.bcp.2026.117700_b0175","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000021952","article-title":"Effect of sodium cantharidinate\/vitamin B6 injection on survival, liver function, immune function, and quality of life in patients with hepatocellular carcinoma: Protocol for a meta-analysis","volume":"99","author":"Zhu","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.bcp.2026.117700_b0180","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jgr.2023.11.004","article-title":"The pharmacological role of Ginsenoside Rg3 in liver diseases: a review on molecular mechanisms","volume":"48","author":"Wang","year":"2024","journal-title":"J. Ginseng Res."},{"issue":"5","key":"10.1016\/j.bcp.2026.117700_b0185","doi-asserted-by":"crossref","first-page":"13919","DOI":"10.1080\/21655979.2022.2074616","article-title":"Ginsenoside Rg3 and sorafenib combination therapy relieves the hepatocellular carcinoma progression through regulating the HK2-mediated glycolysis and PI3K\/Akt signaling pathway","volume":"13","author":"Wei","year":"2022","journal-title":"Bioengineered"},{"issue":"8","key":"10.1016\/j.bcp.2026.117700_b0190","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1142\/S0192415X18500969","article-title":"Ginsenoside Rg3 Decreases NHE1 Expression via Inhibiting EGF-EGFR-ERK1\/2-HIF-1 \u03b1 Pathway in Hepatocellular Carcinoma: a Novel Antitumor Mechanism","volume":"46","author":"Li","year":"2018","journal-title":"Am. J. Chin. Med."},{"issue":"2","key":"10.1016\/j.bcp.2026.117700_b0195","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1148\/radiol.2016150719","article-title":"Prospective Study of Transcatheter Arterial Chemoembolization (TACE) with Ginsenoside Rg3 versus TACE Alone for the Treatment of patients with Advanced Hepatocellular Carcinoma","volume":"280","author":"Zhou","year":"2016","journal-title":"Radiology"},{"issue":"11","key":"10.1016\/j.bcp.2026.117700_b0200","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41389-018-0102-2","article-title":"The combination of cantharidin and antiangiogenic therapeutics presents additive antitumor effects against pancreatic cancer","volume":"7","author":"Xu","year":"2018","journal-title":"Oncogenesis"},{"key":"10.1016\/j.bcp.2026.117700_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107799","article-title":"Pharmacological mechanisms and drug delivery systems of ginsenoside Rg3: a comprehensive review","volume":"216","author":"Yao","year":"2025","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.bcp.2026.117700_b0210","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12950-021-00296-2","article-title":"Ginsenoside Rg3 alleviates septic liver injury by regulating the lncRNA TUG1\/miR-200c-3p\/SIRT1 axis","volume":"18","author":"Wu","year":"2021","journal-title":"J. Inflamm. (Lond.)"},{"issue":"2","key":"10.1016\/j.bcp.2026.117700_b0215","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"issue":"Pt 3","key":"10.1016\/j.bcp.2026.117700_b0220","article-title":"Curcumin reverses irinotecan-acquired resistance in DLD1 colorectal cancer cells: Insights from whole transcriptomic data","volume":"242","author":"Gavrilas","year":"2025","journal-title":"Biochem Pharmacol."},{"issue":"5","key":"10.1016\/j.bcp.2026.117700_b0225","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2174\/1389450119666181022153016","article-title":"Molecular docking: challenges, advances and its use in drug discovery perspective","volume":"20","author":"Saikia","year":"2019","journal-title":"Curr. Drug Targets"},{"issue":"14","key":"10.1016\/j.bcp.2026.117700_b0230","article-title":"Hepatotoxic mechanism of cantharidin: insights and strategies for therapeutic intervention","volume":"13","author":"Jin","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"12","key":"10.1016\/j.bcp.2026.117700_b0235","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.2174\/0113892010244101231024111850","article-title":"Bibliometric analysis and systemic review of cantharidin research worldwide","volume":"25","author":"He","year":"2024","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"2","key":"10.1016\/j.bcp.2026.117700_b0240","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/cbdd.13781","article-title":"Anti-renal interstitial fibrosis effect of norcantharidin is exerted through inhibition of PP2Ac-mediated C-terminal phosphorylation of Smad3","volume":"97","author":"Luo","year":"2021","journal-title":"Chem. Biol. Drug Des."},{"issue":"10","key":"10.1016\/j.bcp.2026.117700_b0245","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.7150\/ijbs.51638","article-title":"Cantharidin inhibits osteosarcoma proliferation and metastasis by directly targeting miR-214-3p\/DKK3 axis to inactivate \u03b2-catenin nuclear translocation and LEF1 translation","volume":"17","author":"Hu","year":"2021","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2026.117700_b0250","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3892\/ol.2017.6168","article-title":"Cantharidin alters the expression of genes associated with the NKG2D-associated immune response in TSGH-8301 human bladder carcinoma cells","volume":"14","author":"Kuo","year":"2017","journal-title":"Oncol. Lett."},{"issue":"29","key":"10.1016\/j.bcp.2026.117700_b0255","doi-asserted-by":"crossref","first-page":"41571","DOI":"10.1021\/acsami.5c05498","article-title":"Cantharidin-Loaded nanomedicine modified with amphiphilic peptides induce immunogenic cell death to enhance PD-1 blockade","volume":"17","author":"Tang","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"22","key":"10.1016\/j.bcp.2026.117700_b0260","doi-asserted-by":"crossref","DOI":"10.1172\/JCI178617","article-title":"Rg3-lipo biomimetic delivery of paclitaxel enhances targeting of tumors and myeloid-derived suppressor cells","volume":"134","author":"Shen","year":"2024","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.bcp.2026.117700_b0265","doi-asserted-by":"crossref","first-page":"13919","DOI":"10.1080\/21655979.2022.2074616","article-title":"Ginsenoside Rg3 and sorafenib combination therapy relieves the hepatocellular carcinoma progression through regulating the HK2-mediated glycolysis and PI3K\/Akt signaling pathway","volume":"13","author":"Wei","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.bcp.2026.117700_b0270","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.metabol.2019.153947","article-title":"AKR1D1 is a novel regulator of metabolic phenotype in human hepatocytes and is dysregulated in non-alcoholic fatty liver disease","volume":"99","author":"Nikolaou","year":"2019","journal-title":"Metabolism"},{"issue":"5","key":"10.1016\/j.bcp.2026.117700_b0275","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.cmet.2025.01.011","article-title":"AKR1D1 suppresses liver cancer progression by promoting bile acid metabolism-mediated NK cell cytotoxicity","volume":"37","author":"Wei","year":"2025","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.bcp.2026.117700_b0280","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jcmgh.2022.09.014","article-title":"PIM1-Induced cytoplasmic expression of rbmy mediates hepatocellular carcinoma metastasis","volume":"15","author":"Chua","year":"2023","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"8","key":"10.1016\/j.bcp.2026.117700_b0285","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.4251\/wjgo.v15.i8.1400","article-title":"Physcion increases the sensitivity of hepatocellular carcinoma to sorafenib through miRNA-370\/PIM1 axis-regulated glycolysis","volume":"15","author":"Pan","year":"2023","journal-title":"World J. Gastrointest Oncol."},{"key":"10.1016\/j.bcp.2026.117700_b0290","article-title":"PIM1 signaling in immunoinflammatory diseases: an emerging therapeutic target","volume":"15","author":"Yang","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2026.117700_b0295","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/hep.32348","article-title":"Monocarboxylate transporter 4 inhibition potentiates hepatocellular carcinoma immunotherapy through enhancing T cell infiltration and immune attack","volume":"77","author":"Fang","year":"2023","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.bcp.2026.117700_b0300","article-title":"ACVR2A attenuation impacts lactate production and hyperglycolytic conditions attracting regulatory T cells in hepatocellular carcinoma","volume":"6","author":"Yasukawa","year":"2025","journal-title":"Cell Rep. Med."},{"issue":"1","key":"10.1016\/j.bcp.2026.117700_b0305","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1186\/s40001-025-03275-y","article-title":"The multidimensional role of SLC16A4 in hepatocellular carcinoma in silico analysis: prognostic significance, metabolic pathways, and immune microenvironment regulation","volume":"30","author":"Jiang","year":"2025","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.bcp.2026.117700_b0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2025.111622","article-title":"Dual roles and therapeutic potential of ALDH3 family members in cancer","volume":"418","author":"Liu","year":"2025","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bcp.2026.117700_b0315","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jsbmb.2019.02.002","article-title":"AKR1D1 regulates glucocorticoid availability and glucocorticoid receptor activation in human hepatoma cells","volume":"189","author":"Nikolaou","year":"2019","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"6","key":"10.1016\/j.bcp.2026.117700_b0320","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s12192-022-01306-9","article-title":"ALDH3B1 protects interfollicular epidermal cells against lipid peroxidation via the NRF2 pathway","volume":"27","author":"Wu","year":"2022","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.bcp.2026.117700_b0325","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.756606","article-title":"The ALDH family contributes to immunocyte infiltration, proliferation and epithelial-mesenchymal transformation in glioma","volume":"12","author":"Wang","year":"2022","journal-title":"Front. Immunol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226000316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226000316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T08:37:08Z","timestamp":1778056628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226000316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":65,"alternative-id":["S0006295226000316"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117700","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrative analyses of network pharmacology and bioinformatics reveal the synergistic antitumor effects of cantharidin and ginsenosides Rg3 on hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117700","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117700"}}